company background image
ASTH logo

Astrana Health NasdaqCM:ASTH Voorraadrapport

Laatste prijs

US$59.89

Marktkapitalisatie

US$2.9b

7D

5.9%

1Y

83.5%

Bijgewerkt

04 Oct, 2024

Gegevens

Financiële gegevens bedrijf +

Astrana Health, Inc.

NasdaqCM:ASTH Voorraadrapport

Marktkapitalisatie: US$2.9b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

ASTH Overzicht aandelen

Astrana Health, Inc, Inc, een op technologie gebaseerd gezondheidszorgmanagementbedrijf dat zich richt op artsen, biedt medische zorgdiensten aan in de Verenigde Staten.

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

US$61.86
FV
3.2% undervalued intrinsic discount
19.87%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
3 days ago author updated this narrative

Astrana Health, Inc. Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Astrana Health
Historische aandelenkoersen
Huidige aandelenkoersUS$59.89
52 Week HoogtepuntUS$61.51
52 Week LaagUS$28.87
Bèta1.22
11 maand verandering27.21%
3 maanden verandering50.63%
1 Jaar Verandering83.54%
33 jaar verandering-19.21%
5 jaar verandering290.16%
Verandering sinds IPO452.49%

Recent nieuws en updates

Astrana Health, Inc.'s (NASDAQ:ASTH) P/E Is Still On The Mark Following 25% Share Price Bounce

Oct 04
Astrana Health, Inc.'s (NASDAQ:ASTH) P/E Is Still On The Mark Following 25% Share Price Bounce

Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 21% Discount?

Sep 26
Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 21% Discount?

Recent updates

Astrana Health, Inc.'s (NASDAQ:ASTH) P/E Is Still On The Mark Following 25% Share Price Bounce

Oct 04
Astrana Health, Inc.'s (NASDAQ:ASTH) P/E Is Still On The Mark Following 25% Share Price Bounce

Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 21% Discount?

Sep 26
Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 21% Discount?

Astrana Health's (NASDAQ:ASTH) Returns On Capital Not Reflecting Well On The Business

Sep 12
Astrana Health's (NASDAQ:ASTH) Returns On Capital Not Reflecting Well On The Business

Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?

Aug 28
Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?

Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors

Aug 02
Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors

Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?

Jun 19
Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?

Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal

Jun 02
Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal

Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 09
Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)

Apr 15
Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)

At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?

Feb 25
At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?

Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Feb 07
Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Apollo Medical Holdings: Good Company, Not Quite A Hold

Jan 17

With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For

Dec 27
With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For

Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled

Nov 08
Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled

Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?

Oct 26
Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?

Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet

Sep 22
Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet

Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down

Aug 04
Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down

A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

Jul 19
A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt

Jun 19
We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt

Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher

May 05
Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher

Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?

Apr 20
Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?

Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Mar 21
Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward

Jan 06
Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward

Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Dec 16
Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Apollo Medical to acquire Valley Oaks Medical Group

Oct 05

Apollo Medical to acquire a San Francisco Bay area physicians' group, health plan

Sep 26

A Look At The Fair Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

Sep 21
A Look At The Fair Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

The Return Trends At Apollo Medical Holdings (NASDAQ:AMEH) Look Promising

Sep 06
The Return Trends At Apollo Medical Holdings (NASDAQ:AMEH) Look Promising

With EPS Growth And More, Apollo Medical Holdings (NASDAQ:AMEH) Makes An Interesting Case

Aug 22
With EPS Growth And More, Apollo Medical Holdings (NASDAQ:AMEH) Makes An Interesting Case

Rendement voor aandeelhouders

ASTHUS HealthcareUS Markt
7D5.9%-1.2%0.3%
1Y83.5%8.2%32.4%

Rendement versus industrie: ASTH overtrof de US Healthcare industrie, die het afgelopen jaar een rendement 10.8 % opleverde.

Rendement versus markt: ASTH overtrof de US markt, die het afgelopen jaar een rendement opleverde van 34.1 %.

Prijsvolatiliteit

Is ASTH's price volatile compared to industry and market?
ASTH volatility
ASTH Average Weekly Movement6.9%
Healthcare Industry Average Movement7.1%
Market Average Movement6.4%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market3.1%

Stabiele aandelenkoers: ASTH heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 7% ) van ASTH is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
19851,800Brandon Simwww.astranahealth.com

Astrana Health, Inc, Inc, een op technologie gebaseerd gezondheidszorgmanagementbedrijf dat zich richt op artsen, biedt medische zorgdiensten aan in de Verenigde Staten. Het is actief in drie segmenten: Care Partners, Care Delivery en Care Enablement. Het bedrijf maakt gebruik van zijn eigen platform voor populatiegezondheidsbeheer en zorgverlening en hanteert een geïntegreerd, op waarde gebaseerd zorgmodel dat de zorgverleners in zijn netwerk in staat stelt zorg te verlenen aan zijn patiënten.

Astrana Health, Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Astrana Health zich tot de beurswaarde?
ASTH fundamentele statistieken
MarktkapitalisatieUS$2.92b
Inkomsten(TTM)US$68.42m
Inkomsten(TTM)US$1.59b

43.0x

Koers/Winstverhouding

1.8x

P/S-verhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
ASTH resultatenrekening (TTM)
InkomstenUS$1.59b
Kosten van inkomstenUS$1.33b
BrutowinstUS$259.20m
Overige uitgavenUS$190.77m
InkomstenUS$68.42m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)1.39
Brutomarge16.28%
Nettowinstmarge4.30%
Schuld/Eigen Vermogen Verhouding92.3%

Hoe presteerde ASTH op de lange termijn?

Bekijk historische prestaties en vergelijking